ArticleInternal medicine (Tokyo, Japan)2023

Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma.

Munehiro Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.